Cargando…
Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
Recent studies of inherited neurodegenerative disorders have suggested a linkage between the propensity toward aggregation of mutant protein and disease onset. This is particularly apparent for polyglutamine (polyQ) diseases caused by expansion of CAG-trinucleotide repeats. However, a quantitative f...
Autores principales: | Sugaya, Keizo, Matsubara, Shiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716343/ https://www.ncbi.nlm.nih.gov/pubmed/19602294 http://dx.doi.org/10.1186/1750-1326-4-29 |
Ejemplares similares
-
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012) -
Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
por: Sugaya, Keizo, et al.
Publicado: (2007) -
Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans
por: Sinnige, Tessa, et al.
Publicado: (2021) -
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021) -
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)